Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported COLL revenue for 2026-06-30 was $393.4M. Net income was -$555.0K. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Use this COLL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the COLL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the COLL SEC filings page. Lician reads the product cache first so this HTML stays unique to Collegium Pharmaceutical Inc even when a live quote feed is slow.
Latest cached year on this hub. Full COLL income, balance, and cash tables.